07.08.2017 07:53:00
|
Sapiens Reports Q2 2017 Financial Results
HOLON, Israel, Aug. 7, 2017 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the second quarter ended June 30, 2017.
Second Quarter Highlights:
- GAAP revenue of $69.0 million, up 30.2% compared to $53.0 million in the second quarter of 2016.
- Non-GAAP revenue of $69.2 million, up 30.4% compared to $53.0 million in the second quarter of 2016.
- GAAP operating loss totaled $3.0 million, compared to operating income of $6.4 million (12.1% operating margin) in the second quarter of 2016. GAAP operating loss for the second quarter of 2017 included $3.9 million in restructuring and cost reduction plan.
- Non-GAAP operating profit totaled $3.2 million (4.7% operating margin), compared to $7.4 million (14.0% operating margin) in the second quarter of 2016.
- GAAP net loss attributable to Sapiens' shareholders totaled $3.6 million or $(0.07) per diluted share compared to net income attributable to Sapiens' shareholders of $5.3 million, or $0.11 per diluted share in the second quarter last year.
- Non-GAAP net income attributable to Sapiens' shareholders totaled $1.9 million or $0.04 per diluted share compared to net income attributable to Sapiens' shareholders of $6.3 million, or $0.13 per diluted share in the second quarter last year.
- Cash, cash equivalents as of June 30, 2017 were $46.4 million, with total debt of $38.0 million.
"Sapiens delivered another quarter of double-digit revenue growth, driven by a mix of organic growth and our recent acquisition of StoneRiver," said Roni Al-Dor, president and CEO of Sapiens. "We witnessed growth across North America, Europe and South Africa. We reported Non-GAAP operating margin of 4.7% which was higher than our guidance of 3-4%. We believe we are on track for continued improvement in our operational profitability.
Al-Dor continued: "We remain very excited about the StoneRiver acquisition and we have made solid steps in combining our two organizations. To date, each StoneRiver division has been fully merged with its peer division at Sapiens, with all of our U.S. P&C activities now in a single group. The StoneRiver and Sapiens sales departments have been integrated, while adding account managers to grow business with existing clients and our marketing departments has been merged into one. All corporate functions and back-office operations, including IT, finance, legal, HR and purchasing, are now also fully integrated. Meanwhile, Sapiens is planning to further leverage our offshore capabilities to drive additional efficiencies and reduce costs throughout the company. Overall, our integration efforts are proceeding according to plan at this time and Sapiens management believes we are on track for the second half of 2017."
During the quarter, we implemented restructuring and cost reduction plan in total of $3.9 million dollars. The restructuring and cost reduction plan included: integration of StoneRiver, de-emphasis of non-core activities in APAC and efficiency measures post the halted development project. The cost savings primarily include headcount reductions as well as other cost saving measures. We continue to expect restructuring and cost reduction expenses of up to $5 million for the full year 2017.
Al-Dor concluded: "Sapiens is maintaining our guidance for 2017 full year revenues of $265 to $275 million (on a non-GAAP basis). We are also maintaining expectations for operating profit margin 13.5-14.5% in the second half of the year (in each case, on a non-GAAP basis) and our expectations for full-year operating profit margin between 9-10% (on a non-GAAP basis)."
Quarterly Results Conference Call
Management will host a conference call and webcast on August 7 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.
Please call the following numbers (at least 10 minutes before the scheduled time) to participate:
North America (toll-free): + 1-888-407-2553; International: +972-3-918-0685; UK: 0-800-917-5108.
The live webcast of the call can be viewed on Sapiens' website at: http://www.sapiens.com/investors/presentations-and-webcast/
If you are unable to join live, a replay of the call will be accessible until August 17, 2017, as follows:
North America: 1-866-500-4953; International: +972-3-925-5947.
A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.
Non-GAAP Financial Measures
This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, and non-GAAP basic and diluted earnings per share.
Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition, acquisition-related costs, restructuring and cost reduction plan, loss on sales of Marketable Securities and tax adjustment regarding non-GAAP adjustments.
Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.
To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.
Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.
The Company defines Adjusted EBITDA as net profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition, acquisition-related costs, restructuring and cost reduction plan, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.
The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.
About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 400 financial services organizations. The Sapiens team of approximately 2,500 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.
Forward Looking Statement
Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.
These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2016, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.
Investors and Media Contact
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
U.S. Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: yaffa.cohen-ifrah@sapiens.com
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
U.S. dollars in thousands (except per share amounts) | |||||||||
Three months ended | Six months ended | ||||||||
June 30 | June 30 | ||||||||
2017 | 2016 | 2017 | 2016 | ||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||
Revenue | 69,049 | 53,030 | 125,583 | 102,597 | |||||
Cost of revenue | 45,740 | 31,781 | 83,128 | 61,388 | |||||
Gross profit | 23,309 | 21,249 | 42,455 | 41,209 | |||||
Operating expenses: | |||||||||
Research and development, net | 8,952 | 4,001 | 15,147 | 7,254 | |||||
Selling, marketing, general and administrative | 17,343 | 10,841 | 31,931 | 21,297 | |||||
Total operating expenses | 26,295 | 14,842 | 47,078 | 28,551 | |||||
Operating income (loss) | (2,986) | 6,407 | (4,623) | 12,658 | |||||
Financial expense (income), net | 709 | (326) | 1,147 | (406) | |||||
Taxes and other expenses (income), net | (109) | 1,468 | 58 | 2,926 | |||||
Net income (loss) | (3,586) | 5,265 | (5,828) | 10,138 | |||||
Attributable to non-controlling interest | (8) | (68) | (38) | (82) | |||||
Net income (loss) attributable to Sapiens' shareholders | (3,578) | 5,333 | (5,790) | 10,220 | |||||
Basic earnings per share | (0.07) | 0.11 | (0.12) | 0.21 | |||||
Diluted earnings per share | (0.07) | 0.11 | (0.12) | 0.21 | |||||
Weighted average number of shares outstanding used to | 49,124 | 48,948 | 49,086 | 48,883 | |||||
Weighted average number of shares outstanding used to | 49,124 | 49,759 | 49,086 | 49,659 |
Summary of Non-GAAP Financial Information | |||||||||||
U.S. dollars in thousands (except per share amounts) | |||||||||||
Three months ended | Six months ended | ||||||||||
June 30 | June 30 | ||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||||
Revenues | 69,167 | 100% | 53,030 | 100% | 125,701 | 100% | 102,597 | 100% | |||
Gross profit | 26,389 | 38.2% | 22,726 | 42.9% | 46,859 | 37.6% | 44,300 | 43.2% | |||
Operating profit | 3,217 | 4.7% | 7,426 | 14.0% | 4,915 | 3.9% | 14,774 | 14.4% | |||
Net income to shareholders | 1,927 | 2.8% | 6,251 | 11.8% | 3,111 | 2.5% | 12,237 | 11.9% | |||
Adjusted EBITDA | 4,179 | 6.0% | 8,082 | 15.2% | 6,753 | 5.4% | 16,037 | 15.6% | |||
Basic earnings per share | 0.04 | 0.13 | 0.06 | 0.25 | |||||||
Diluted earnings per share | 0.04 | 0.13 | 0.06 | 0.25 |
Non-GAAP Revenues by Geographic Breakdown | |||||||||
U.S. dollars in thousands | |||||||||
Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | |||||
North America | 28,544 | 19,465 | 21,107 | 19,706 | 17,601 | ||||
Europe & South Africa | 36,711 | 32,489 | 28,292 | 28,675 | 26,124 | ||||
APAC | 3,912 | 4,580 | 7,714 | 8,099 | 9,305 | ||||
Total | 69,167 | 56,534 | 57,113 | 56,480 | 53,030 |
Adjusted EBITDA Calculation | ||||||||
U.S. dollars in thousands | ||||||||
Three months ended | Six months ended | |||||||
June 30 | June 30 | |||||||
2017 | 2016 | 2017 | 2016 | |||||
GAAP operating profit (loss) | (2,986) | 6,407 | (4,623) | 12,658 | ||||
Non-GAAP adjustments: | ||||||||
Amortization of capitalized software | 1,235 | 1,256 | 2,256 | 2,665 | ||||
Amortization of other intangible assets | 1,727 | 495 | 2,981 | 1,006 | ||||
Capitalization of software development | (1,850) | (1,396) | (2,915) | (2,780) | ||||
Stock-based compensation | 456 | 482 | 911 | 940 | ||||
Compensation related to acquisition and | 617 | 182 | 2,287 | 285 | ||||
Restructuring and cost reduction plan | 3,900 | - | 3,900 | - | ||||
Valuation adjustment on acquired | 118 | - | 118 | - | ||||
Non-GAAP operating profit | 3,217 | 7,426 | 4,915 | 14,774 | ||||
Depreciation | 962 | 656 | 1,838 | 1,263 | ||||
Adjusted EBITDA | 4,179 | 8,082 | 6,753 | 16,037 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES | ||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | ||||||||
U.S. dollars in thousands (except per share amounts) | ||||||||
Three months ended | Six months ended | |||||||
June 30 | June 30 | |||||||
2016 | 2015 | 2016 | 2015 | |||||
GAAP revenue | 69,049 | 53,030 | 125,583 | 102,597 | ||||
Valuation adjustment on acquired deferred revenue and long-term contract | 118 | - | 118 | - | ||||
Non-GAAP revenue | 69,167 | 53,030 | 125,701 | 102,597 | ||||
GAAP gross profit | 23,309 | 21,249 | 42,455 | 41,209 | ||||
Revenue adjustment | 118 | - | 118 | - | ||||
Amortization of capitalized software | 1,235 | 1,256 | 2,256 | 2,665 | ||||
Amortization of other intangible assets | 1,727 | 221 | 2,030 | 426 | ||||
Non-GAAP gross profit | 26,389 | 22,726 | 46,859 | 44,300 | ||||
GAAP operating income (loss) | (2,986) | 6,407 | (4,623) | 12,658 | ||||
Gross profit adjustments | 3,080 | 1,477 | 4,404 | 3,091 | ||||
Capitalization of software development | (1,850) | (1,396) | (2,915) | (2,780) | ||||
Amortization of other intangible assets | - | 274 | 951 | 580 | ||||
Stock-based compensation | 456 | 482 | 911 | 940 | ||||
Compensation related to acquisition and acquisition-related costs | 617 | 182 | 2,287 | 285 | ||||
Restructuring and cost reduction plan | 3,900 | - | 3,900 | - | ||||
Non-GAAP operating income | 3,217 | 7,426 | 4,915 | 14,774 | ||||
GAAP net income (loss) attributable to Sapiens' shareholders | (3,578) | 5,333 | (5,790) | 10,220 | ||||
Operating income (loss) adjustments | 6,203 | 1,019 | 9,538 | 2,116 | ||||
Adjustment to redeemable non-controlling interest | - | 37 | - | 103 | ||||
Loss on sales of Marketable Securities | - | - | 230 | - | ||||
Other | (698) | (138) | (867) | (202) | ||||
Non-GAAP net income attributable to Sapiens' shareholders | 1,927 | 6,251 | 3,111 | 12,237 | ||||
Non-GAAP basic earnings per share | 0.04 | 0.13 | 0.06 | 0.25 | ||||
Non-GAAP diluted earnings per share | 0.04 | 0.13 | 0.06 | 0.25 | ||||
Weighted average number of shares outstanding used to compute | 49,124 | 48,948 | 49,086 | 48,883 | ||||
Weighted average number of shares outstanding used to compute | 49,887 | 49,759 | 49,906 | 49,659 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | |||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
U.S. Dollars in thousands | |||||
June 30, | December 31, | ||||
2017 | 2016 | ||||
(unaudited) | (unaudited) | ||||
ASSETS | |||||
CURRENT ASSETS | |||||
Cash and cash equivalents | 46,416 | 60,908 | |||
Trade receivables, net | 50,026 | 34,684 | |||
Other receivables and prepaid expenses | 8,612 | 6,389 | |||
Marketable securities | - | 18,220 | |||
Total current assets | 105,054 | 120,201 | |||
LONG-TERM ASSETS | |||||
Marketable securities | - | 17,228 | |||
Property and equipment, net | 10,435 | 9,807 | |||
Severance pay fund | 4,380 | 4,041 | |||
Goodwill and intangible assets, net | 224,570 | 101,951 | |||
Other long-term assets | 3,270 | 4,623 | |||
Total long-term assets | 242,655 | 137,650 | |||
TOTAL ASSETS | 347,709 | 257,851 | |||
LIABILITIES AND EQUITY | |||||
CURRENT LIABILITIES | |||||
Trade payables | 7,566 | 6,562 | |||
Accrued expenses and other liabilities | 48,344 | 32,049 | |||
Deferred revenue | 24,297 | 9,137 | |||
Current maturities of long-term loans | 8,000 | - | |||
Total current liabilities | 88,207 | 47,748 | |||
LONG-TERM LIABILITIES | |||||
Other long-term liabilities | 23,246 | 9,864 | |||
Long Term Loans | 30,000 | - | |||
Accrued severance pay | 5,398 | 4,940 | |||
Total long-term liabilities | 58,644 | 14,804 | |||
REDEEMABLE NON-CONTROLLING INTEREST | 908 | 908 | |||
EQUITY | 199,950 | 194,391 | |||
TOTAL LIABILITIES AND EQUITY | 347,709 | 257,851 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | ||
CONSOLIDATED STATEMENT OF CASH FLOW | ||
U.S. dollars in thousands | ||
For the six months ended June 30 | ||
2017 | 2016 | |
(unaudited) | (unaudited) | |
Cash flows from operating activities: | ||
Net income (loss) | (5,876) | 10,138 |
Reconciliation of net income (loss) to net cash provided by (used in) | ||
Depreciation and amortization | 7,075 | 4,934 |
Amortization of premium, accrued interest and loss on sales of | 509 | (262) |
Stock-based compensation related to options issued to employees | 911 | 940 |
Net changes in operating assets and liabilities, net of amount acquired: | ||
Trade receivables | (3,236) | (1,599) |
Deferred tax assets | (1,662) | 52 |
Other operating assets | 928 | (980) |
Trade payables | (512) | 1,574 |
Other operating liabilities | 1,643 | (50) |
Deferred revenues | 7,241 | 4,401 |
Severance pay | 30 | (10) |
Net cash provided by operating activities | 7,051 | 19,138 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (1,102) | (2,013) |
Purchase of marketable securities, net of interest received | - | (2,359) |
Proceeds from sales of marketable securities | 35,369 | 2,677 |
Payments for business acquisition, net of cash acquired | (94,951) | - |
Capitalized software development costs | (2,915) | (2,780) |
Net cash used in investing activities | (63,599) | (4,475) |
Cash flows from financing activities: | ||
Proceeds from employee stock options exercised | 385 | 686 |
Payment to shareholders in respect of acquisition | - | (1,440) |
Loan received net of Repayment of loan | 37,974 | - |
Distribution of dividend | - | (8,809) |
Net cash provided by (used in) financing activities | 38,359 | (9,563) |
Effect of exchange rate changes on cash and cash equivalents | 3,697 | 820 |
Increase (decrease) in cash and cash equivalents | (14,492) | 5,920 |
Cash and cash equivalents at the beginning of period | 60,908 | 54,351 |
Cash and cash equivalents at the end of period | 46,416 | 60,271 |
View original content:http://www.prnewswire.com/news-releases/sapiens-reports-q2-2017-financial-results-300500197.html
SOURCE Sapiens International Corporation
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sapiens International Corporation NVShsmehr Nachrichten
Keine Nachrichten verfügbar. |